Crohn's disease

• Evaluation of Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN’s … Recruiting
  2024-517794-24-00 4 2024-10-24 "crohn disease"
• A Phase 2b Study to Evaluate the Efficacy and Safety of Oral TAK-279 in Subjects with Moderately to Severely Active Crohn’s Disease Recruiting
  2023-506704-14-00 4 2024-09-04 "Moderately to Severely Active Crohn's Disease"
• A Study to Evaluate Whether Healing all Bowel Wall Layers is a Superior Treatment Target in Patients with Active Crohn’s Disease (CD). Recruiting
  2023-509096-16-00 6 2024-07-31 "Moderately to Severely Active Crohn’s Disease"
• A Phase 2 Study to Evaluate MORF-057 in Adults with Moderately to Severely Active Crohn’s Disease Recruiting
  2023-508158-24-00 4 2024-06-25 "Moderately to Severely Active Crohn’s Disease"
• Efficacy, Safety, and Pharmacokinetics of Guselkumab in Pediatric Participants with Moderately to Severely Active Crohn’s Disease Recruiting
  2023-504735-41-00 5 2024-03-05 "Moderately to Severely Active Crohn's Disease"
• FAPi-PET imaging of in vivo early fistula healing in perianal Crohn’s disease: PERSIST study Recruiting
  2023-505317-25-00 6 2023-11-24 "perianal Crohn's fistula"
• Prevention of postoperative endoscopic disease recurrence in Crohn’s disease: a multicentric study that compares the systematic start of bio … Recruiting
  2022-500311-39-00 6 2022-09-08 "Patients with Crohn's disease undergoing surgery and having "
• Fecal microbiota transplantation in Crohn’s disease as relay after anti-TNF withdrawal (MIRACLE) Recruiting
  2024-511822-30-00 11 2021-09-22 "Crohn’s disease"
• Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (risankizumab biosimilar), with EU-approved Skyrizi®, and US … Recruitment ended
  2025-522345-21-00 1 2025-11-11 "Active psoriatic arthritis"
• Crohn's Disease: Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn’s Disease Recruitment ended
  2024-516023-13-00 5 2025-01-23
• A trial to learn how safe AZD7798 is and how well it works in adults with ileal Crohn’s disease who have an ileostomy Recruitment ended
  2024-514407-33-00 4 2024-12-10 "Crohn’s Disease and an Ileostomy"
• Transmural Healing and Disease Modifying Effect of Guselkumab in Crohn’s Disease Patients Recruitment ended
  2023-504040-34-01 5 2024-11-12 "Crohn’s Disease"
• Subcutaneous infliximab after a previous intravenous dose optimization (AMARETTO trial) Recruitment ended
  2023-508166-15-00 6 2024-04-29 "Ulcerative colitis (UC), Inflammatory bowel disease type unc"
• A Study of Mirikizumab (LY3074828) in Pediatric Participants with Crohn’s Disease (AMAY) Recruitment ended
  2024-511472-32-00 5 2024-03-12 "Crohn's Disease"
• A clinical trial to assess the safety and effects of AGMB-129 compared to placebo in patients with fibrostenotic Crohn’s disease. Recruitment ended
  2022-502789-26-01 4 2023-11-03 "Fibrostenotic Crohn’s Disease"
• GRAVITI - A Phase 3 Study to Evaluate the Efficacy and Safety of Guselkumab Subcutaneous Induction Therapy in Participants with Moderately t … Recruitment ended
  2023-504737-41-00 5 2022-06-10 "Moderately to Severely Active Crohn's Disease"
• Management of moderate POstoperative recurrence in Crohn's disease: a randoMizEd contROLled trial of therapeutic escalation, the POMEROL tri … Recruitment ended
  2023-508242-18-00 6 2021-12-21
• A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Clinical Study Participants (2 to <18 Year … Recruitment ended
  2022-501067-40-00 5 2021-11-30 "Moderately to Severely Active Ulcerative Colitis"
• An Open-Label Extension and long-term efficacy and safety monitoring study of patients with Crohn's disease previously included in the loss … Recruitment ended
  2024-514326-23-00 11 2021-09-10
• A Study of the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease Recruitment ended
  2023-504736-18-00 10 2018-07-26 "Moderately to Severely Active Crohn's Disease"
• A Placebo controlled Maintenance and Long-term Extension Study of the Efficacy and Safety of Risankizumab in Participants with Crohn's Disea … Recruitment ended
  2023-506399-28-00 5 2017-11-08 "Crohn's Disease"
• A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Crohn's Disease who Comple … Recruitment ended
  2023-504951-29-00 5 2017-07-27 "Chron's Disease"
• Comparison of Prefilled syringe and Autoinjector presentations of FYB202 Ended
  2025-522422-13-00 2 2025-11-15 "Chronic inflammatory diseases"
• An open-label, randomized, single-dose, two-period, two-treatment, crossover bioequivalence study with GP-IMP-001 in healthy male volunteers … Ended
  2025-522921-37-00 2 2025-10-22 "inteneded for treatment of - active rheumatoid arthritis in "

Showing 25–48 of 62 trials